TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Neglected Tropical Diseases Drugs and Vaccine Market Research Report 2023

Global Neglected Tropical Diseases Drugs and Vaccine Market Research Report 2023

  • Category:Life Sciences
  • Published on : 15 February 2023
  • Pages :88
  • Formats:
  • Report Code:SMR-7567611
OfferClick for best price

Best Price: $2320

Neglected Tropical Diseases Drugs Vaccine Market Size, Share 2023


Market Analysis and Insights: Global Neglected Tropical Diseases Drugs Vaccine Market

The global Neglected Tropical Diseases Drugs Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neglected Tropical Diseases Drugs Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neglected Tropical Diseases Drugs Vaccine market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neglected Tropical Diseases Drugs Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neglected Tropical Diseases Drugs Vaccine market.

Global Neglected Tropical Diseases Drugs Vaccine Scope and Market Size

Neglected Tropical Diseases Drugs and Vaccine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Neglected Tropical Diseases Drugs and Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2032.

Segment by Type

Malaria

Ebola

Dengue

Chagas

Leishmaniasis

Other

Segment by Application

Drugs

Vaccines

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Artecef BV

GlaxoSmithKline

AstraZeneca

Novartis

Sanofi-Aventis

Ranbaxy Labs

Lupin

Macleods Pharmaceuticals

Cipla

Romark Laboratories

Toyama Chemica

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Neglected Tropical Diseases Drugs Vaccine product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Neglected Tropical Diseases Drugs Vaccine, with price, sales, revenue, and global market share of Neglected Tropical Diseases Drugs Vaccine from 2019 to 2022.

Chapter 3, the Neglected Tropical Diseases Drugs Vaccine competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Neglected Tropical Diseases Drugs Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Neglected Tropical Diseases Drugs Vaccine market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Neglected Tropical Diseases Drugs Vaccine.

Chapter 13, 14, and 15, to describe Neglected Tropical Diseases Drugs Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Neglected Tropical Diseases Drugs Vaccine Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Neglected Tropical Diseases Drugs and Vaccine Market Research Report 2023
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2022
Forecast Year 2030
Number of Pages 88 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Malaria
1.2.3 Ebola
1.2.4 Dengue
1.2.5 Chagas
1.2.6 Leishmaniasis
1.2.7 Other
1.3 Market by Application
1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Drugs
1.3.3 Vaccines
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2018-2032)
2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Region
2.2.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Region (2018-2023)
2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2023-2032)
2.3 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
2.3.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
2.3.2 Neglected Tropical Diseases Drugs and Vaccine Market Drivers
2.3.3 Neglected Tropical Diseases Drugs and Vaccine Market Challenges
2.3.4 Neglected Tropical Diseases Drugs and Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue
3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2018-2023)
3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
3.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2022
3.5 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
3.6 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
3.7 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Type
4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2018-2023)
4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2023-2032)
5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application
5.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2018-2032)
6.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023)
6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2018-2032)
7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023)
7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (2018-2032)
8.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023)
8.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size (2018-2032)
9.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023)
9.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2018-2032)
10.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023)
10.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Artecef BV
11.1.1 Artecef BV Company Detail
11.1.2 Artecef BV Business Overview
11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
11.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.1.5 Artecef BV Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
11.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.2.5 GlaxoSmithKline Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
11.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Detail
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.5.5 Sanofi-Aventis Recent Development
11.6 Ranbaxy Labs
11.6.1 Ranbaxy Labs Company Detail
11.6.2 Ranbaxy Labs Business Overview
11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
11.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.6.5 Ranbaxy Labs Recent Development
11.7 Lupin
11.7.1 Lupin Company Detail
11.7.2 Lupin Business Overview
11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
11.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.7.5 Lupin Recent Development
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Detail
11.8.2 Macleods Pharmaceuticals Business Overview
11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
11.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.8.5 Macleods Pharmaceuticals Recent Development
11.9 Cipla
11.9.1 Cipla Company Detail
11.9.2 Cipla Business Overview
11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
11.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.9.5 Cipla Recent Development
11.10 Romark Laboratories
11.10.1 Romark Laboratories Company Detail
11.10.2 Romark Laboratories Business Overview
11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
11.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.10.5 Romark Laboratories Recent Development
11.11 Toyama Chemica
11.11.1 Toyama Chemica Company Detail
11.11.2 Toyama Chemica Business Overview
11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
11.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.11.5 Toyama Chemica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Malaria
Table 3. Key Players of Ebola
Table 4. Key Players of Dengue
Table 5. Key Players of Chagas
Table 6. Key Players of Leishmaniasis
Table 7. Key Players of Other
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2018-2023)
Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2023-2032)
Table 14. Neglected Tropical Diseases Drugs and Vaccine Market Trends
Table 15. Neglected Tropical Diseases Drugs and Vaccine Market Drivers
Table 16. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 17. Neglected Tropical Diseases Drugs and Vaccine Market Restraints
Table 18. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players (2018-2023)
Table 20. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2022)
Table 21. Ranking of Global Top Neglected Tropical Diseases Drugs and Vaccine Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
Table 25. Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2018-2023)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2023-2032)
Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2018-2023)
Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2023-2032)
Table 35. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032) & (US$ Million)
Table 37. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032) & (US$ Million)
Table 39. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2023-2032) & (US$ Million)
Table 41. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032) & (US$ Million)
Table 43. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032) & (US$ Million)
Table 45. Artecef BV Company Detail
Table 46. Artecef BV Business Overview
Table 47. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product
Table 48. Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 49. Artecef BV Recent Development
Table 50. GlaxoSmithKline Company Detail
Table 51. GlaxoSmithKline Business Overview
Table 52. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product
Table 53. GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 54. GlaxoSmithKline Recent Development
Table 55. AstraZeneca Company Detail
Table 56. AstraZeneca Business Overview
Table 57. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product
Table 58. AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 59. AstraZeneca Recent Development
Table 60. Novartis Company Detail
Table 61. Novartis Business Overview
Table 62. Novartis Neglected Tropical Diseases Drugs and Vaccine Product
Table 63. Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Sanofi-Aventis Company Detail
Table 66. Sanofi-Aventis Business Overview
Table 67. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product
Table 68. Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 69. Sanofi-Aventis Recent Development
Table 70. Ranbaxy Labs Company Detail
Table 71. Ranbaxy Labs Business Overview
Table 72. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product
Table 73. Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 74. Ranbaxy Labs Recent Development
Table 75. Lupin Company Detail
Table 76. Lupin Business Overview
Table 77. Lupin Neglected Tropical Diseases Drugs and Vaccine Product
Table 78. Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 79. Lupin Recent Development
Table 80. Macleods Pharmaceuticals Company Detail
Table 81. Macleods Pharmaceuticals Business Overview
Table 82. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product
Table 83. Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 84. Macleods Pharmaceuticals Recent Development
Table 85. Cipla Company Detail
Table 86. Cipla Business Overview
Table 87. Cipla Neglected Tropical Diseases Drugs and Vaccine Product
Table 88. Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 89. Cipla Recent Development
Table 90. Romark Laboratories Company Detail
Table 91. Romark Laboratories Business Overview
Table 92. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product
Table 93. Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 94. Romark Laboratories Recent Development
Table 95. Toyama Chemica Company Detail
Table 96. Toyama Chemica Business Overview
Table 97. Toyama Chemica Neglected Tropical Diseases Drugs and VaccineProduct
Table 98. Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 99. Toyama Chemica Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type: 2022 VS 2032
Figure 2. Malaria Features
Figure 3. Ebola Features
Figure 4. Dengue Features
Figure 5. Chagas Features
Figure 6. Leishmaniasis Features
Figure 7. Other Features
Figure 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application in 2022 & 2032
Figure 9. Drugs Case Studies
Figure 10. Vaccines Case Studies
Figure 11. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region: 2022 VS 2032
Figure 15. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players in 2022
Figure 16. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2022
Figure 18. North America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 19. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2018-2032)
Figure 20. United States Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 21. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 22. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2018-2032)
Figure 24. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. France Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 30. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2018-2032)
Figure 32. China Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. India Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 38. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2018-2032)
Figure 40. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 41. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 42. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2018-2032)
Figure 44. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 45. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 46. Artecef BV Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 50. Sanofi-Aventis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 51. Ranbaxy Labs Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 52. Lupin Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 53. Macleods Pharmaceuticals Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 54. Cipla Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 55. Romark Laboratories Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 56. Toyama Chemica Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount